Neurological complications of COVID-19 in elderly people

Close metadata

Recommended articles:

Neuprotection of post-acute COVID-19 cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):106-111

Thoracoscopic thymectomy for myasthenia gravis and non-invasive thymoma after COVID-19 pneumonia. Pirogov Russian Journal of Surgery. 2024;(8):26-33

Acute dissecting aortic aneurysm with rupture in a patient with Noonan syndrome following SARS-CoV-2 re-infection. Russian Journal of Preventive Medicine. 2024;(8):73-75

Risk Factors of Bleedings in Patients with COVID-19 Receiving Anticoagulants for Venous Thromboembolism Prevention. Journal of Venous Disorders. 2024;(3):222-231

Clinical effect of selective hemosorption of cytokines in patients with severe COVID-19: a systematic review. Russian Journal of Anesthesiology and Reanimatology. 2024;(5):103-111

Assessment of cytokine status in patients with oncological diseases and severe COVID-19. Russian Journal of Evidence-Based Gastroenterology. 2024;(3):60-66

Features of the course of COVID-19 in patients with cancer in the intensive care unit. Russian Journal of Pain. 2024;(3):55-62

Heart failure with preserved ejection fraction: morphofunctional state of the heart throughout 2 years after COVID-19 pneumonia. Russian Cardiology Bulletin. 2024;(3):53-61

ALDH1, CD133, CD34-positive cancer stem cells in lung adenocarcinoma in patients who had a new coronavirus infection and retained the persistence of viral proteins in the lung tissue. Russian Journal of Archive of Pathology. 2024;(5):5-14

Factors affecting the quality of life of patients with neurological manifestations of post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):44-50

Virus SARS-CoV2 (beta-coronavirus) can induce severe pneumonia with acute respiratory distress syndrome, respiratory failure and multiorgan dysfunction. As more we learned about Covid-19, we understand that SARS-CoV-2 have neuroinvasive properties and can cause different neurological complications. In this article we discusses about the features of neurological sequences of Covid-19 in elderly people.

Keywords:

Covid-19

coronavirus

SARS-CoV2

neurological complications

encephalopathy

neurodegenerative disorders

Authors:

Nikitina A.J.

Russian Medical Academy of continuous Professional Education

Chimagomedova A.Sh.

Russian Medical Academy of Continuous Professional Education

Levin O.S.

Russian Medical Academy of Continuous Professional Education

SPIN RSCI: 5342-1373
Scopus AuthorID: 57147160800
ORCID: 0000-0003-3872-5923

Received:

22.09.2021

Accepted:

27.09.2021

List of references:

Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2. J of Virology. 2008;82(15):7264-7275. https://doi.org/10.1128/jvi.00737-08
Xu J, Zhong S, Liu J, Li L, Li Y, Wu X, Li Z, Deng P, Zhang J, Zhong N, Ding Y, Jiang Y. Detection of Severe Acute Respiratory Syndrome Coronavirus in the Brain: Potential Role of the Chemokine Mig in Pathogenesis. Clinical Infectious Diseases. 2005;41(8):1089-1096. https://doi.org/10.1086/444461
Roy D, Tripathy S, Kumar Kar S, Sharma N, Kumar Verma S, Kaushal V. Study of Knowledge, Attitude, Anxiety & Perceived Mental Healthcare Need in Indian Population During COVID-19 Pandemic. Asian Journal of Psychiatry. 2020;51:102083. https://doi.org/10.1016/j.ajp.2020.102083
Mao L, Jin H, Wang H, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690. https://doi.org/10.1001/jamaneurol.2020.1127
Bosso M, Thanaraj TA, Abu-Farha M, Alanbaei M, Abubaker J, Al-Mulla F. The Two Faces of ACE2: the Role of ACE2 Receptor and its Polymorphisms in Hypertension and COVID-19. Molecular Therapy-Methods & Clinical Development. 2020;45:56-61. https://doi.org/10.1016/j.omtm.2020.06.017
Varga Z, Flammer AF, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial Cell Infection and Endotheliitis in COVID-19. The Lancet. 2020;395(10234):1417-1418. https://doi.org/10.1016/S0140-6736(20)30937-5
Achar A, Ghosh C. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Barrier Relevance. Cells. 2020;9(11):2360. https://doi.org/10.3390/cells9112360
Lee KW, Khan AHKY, Ching SM, Chia PK, Loh WC, Rashid AMA, Baharin J, Mat LNI, Sulaiman WAW, Devaraj NK, Sivaratnam D, Basri H, Hoo FK. Stroke and Novel Coronavirus Infection in Humans: A Systematic Review and Meta-Analysis. Frontiers in Neurology. 2020;11:45-51. https://doi.org/10.3389/fneur.2020.579070
Gkrouzman E, Barbhaiya M, Erkan D, Lockshin MD. Reality Check on Antiphospholipid Antibodies in COVID‐19 — Associated Coagulopathy. Arthritis & Rheumatology. 2021;73(1):173-174. https://doi.org/10.1002/art.41472
Bowles L, Platton S, Yartey N, Dave M, Lee K, Hart DP, MacDonald V, Green L, Sivapalaratnam S, Pasi KJ, MacCallum P. Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19. New England Journal of Medicin. 2020;383(3):288-290. https://doi.org/10.1056/NEJMc2013656
de Oliveira RMF, de Souza Aguiar PHC, de Paula RWRM, Simões CEN, Almeida LG, Barceló A, de Siqueira Galil AG. Stroke in Patients Infected by the Novel Coronavirus and its Causal Mechanisms: A Narrative Review. Journal of the American College of Emergency Physicians Open. 2020;5:34-39. https://doi.org/10.1002/emp2.12332
Ritchie K, Chan D. The Emergence of Cognitive COVID. World Psychiatry. 2021;20(1):52-53. https://doi.org/10.1002/wps.20837
Alexopoulos H, Magira E, Bitzogli K, Kafasi N, Vlachoyiannopoulos P, Tzioufas A, Kotanidou A, Dalakas. Anti — SARS-CoV-2 Antibodies in the CSF, Blood-brain barrier Dysfunction, and Neurological Outcome Studies in 8 Stuporous and Komatose patients. Neurol Neuroimmunol Neuroinflamm. 2020;7:e893. https://doi.org/10.1212/NXI.0000000000000893
Rege S. COVID-19 and the Brain — Pathogenesis and Neuropsychiatric Manifestations of SARS-CoV-2 CNS Involvement MRCPsych, FRANZCP. 2020.
Qureshi AI, Abd-Allah F, Al-Senani F, Aytac E, Borhani-Haghighi A, Ciccone A, Gomez CR, Gurkas E, Hsu CY, Jani V, Jiao L, Kobayashi A, Lee J, Liaqat J, Mazighi M, Parthasarathy R, Steiner T, Suri MFK, Toyoda K, Ribo M, Gongora-Rivera F, Oliveira-Filho J, Uzun G, Wang Y. Management of Acute Ischemic Stroke in Patients with COVID-19 Infection: Report of an International Panel. International Journal of Stroke. 2020;15(5):540-554. https://doi.org/10.1177/1747493020923234
Dries DJ, Hussein HM. Coronavirus Disease 2019 and Stroke. Air Medical Journal. 2021;45:56-61. https://doi.org/10.1016/j.amj.2020.12.003
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, Ye C, Zhang P, Xing Y, Guo H, Tang W. Risk Factors of Critical & Mortal COVID-19 Cases: A Systematic Literature Review and Meta-analysis. Journal of Infection. 2020. https://doi.org/10.1016/j.jinf.2020.04.021
Jillella DV, Janocko NJ, Nahab F, Benameur K, Greene JG, Wright WL, Obideen M, Rangaraju S. Ischemic Stroke in COVID-19: An Urgent Need for Early Identification and Management. Plos one. 2020;15(9):e0239443. https://doi.org/10.1371/journal.pone.0239443
Yaghi S, Ishida K, Torres J, Grory BM, Raz E, Humbert K, Henninger N, Trivedi T, Lillemoe K, Alam S, Sanger M, Kim S, Scher E, Dehkharghani S, Wachs M, Tanweer O, Volpicelli F, Bosworth B, Lord A, Frontera J. SARS-CoV-2 and Stroke in a New York Healthcare System. Stroke. 2020;51(7):2002-2011. https://doi.org/10.1161/STROKEAHA.120.030335
Kihira S, Schefflein J, Mahmoudi K, Rigney B, Delman BN, Mocco J, Doshi A, Belani P. Association of Coronavirus Disease (COVID-19) with Large Vessel Occlusion Strokes: a Case-Control Study. American Journal of Roentgenology. 2021;216(1):150-156. https://doi.org/10.2214/AJR.20.23847
Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, Humphries F, Jäger HR, Losseff NA, Perry RJ, Shah S, Simister RJ, Turner D, Chandratheva A, Werring DJ. Characteristics of Ischaemic Stroke Associated with COVID-19. Journal of Neurology, Neurosurgery & Psychiatry. 2020;91(8):889-891. https://doi.org/10.1136/jnnp-2020-323586
Ntaios G, Michel P, Georgiopoulos G, Guo Y, Li W, Xiong J, Calleja P, Ostos F, González-Ortega G, Fuentes B, de Leciñana MA, Díez-Tejedor E, García-Madrona S, Masjuan J, DeFelipe A, Turc G, Gonçalves B, Domigo V, Dan G-A, Vezeteu R, Christensen H, Christensen LM, Meden P, HajdarevicL, Rodriguez-Lopez A, Díaz-Otero F, García-Pastor A, Gil-Nuñez A, Maslias E, Strambo D, Werring DJ, Chandratheva A, Benjamin L, Simister R, Perry R. Characteristics and Outcomes in Patients with COVID-19 and Acute Ischemic Stroke: the Global COVID-19 Stroke Registry. Stroke. 2020;51(9):254-258. https://doi.org/10.1161/STROKEAHA.120.031208
Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the Nervous System. Cell. 2020;23:45-49. https://doi.org/10.1016/j.cell.2020.08.028
Mishra AK, Sahu KK, Lal A, Sargent J. Patterns of Heart Injury in COVID‐19 and Relation to Outcome. Journal of Medical Virology. 2020;92(10):1747-1747. https://doi.org/10.1002/jmv.25847
Peng K-P. Association Between COVID-19 and Headache: What Evidence and History Tell Us. SAGE Journals. 2020;40(13):1403-1405. https://doi.org/10.1177/0333102420965969
Spence JD, De Freitas GR, Pettigrew LC, Ay H, Liebeskind DS, Kase CS, Del Brutto OH, Hankey GJ, Venketasubramanian N. Mechanisms of Stroke in COVID-19. Cerebrovascular Diseases. 2020;49(4):451-458. https://doi.org/10.1159/000509581
Kwan J, Brown M, Bentley P, Brown Z, D’Anna L, Hall C, Halse O, Jamil S, Jenkins H, Kalladka D, Patel M, Rane N, Singh A, Taylor E, Venter M, Lobotesis K, Banerjee S. Impact of COVID-19 Pandemic on a Regional Stroke Thrombectomy Service in the United Kingdom. Cerebrovascular Diseases. 2020;24:1-7. https://doi.org/10.1159/000512603
Thachil J. The Versatile Heparin in COVID‐19. Journal of Thrombosis and Haemostasis. 2020;18(5):1020-1022. https://doi.org/10.1111/jth.14821
Diener H-C, Berlit P, Masjuan J. COVID-19: Patients with Stroke or Risk of Stroke. European Heart Journal Supplements. 2020;22(Suppl P):25-28. https://doi.org/10.1093/eurheartj/suaa174
Benger M, Williams O, Siddiqui J, Sztriha L. Intracerebral Haemorrhage (ICH) and COVID-19: Clinical Characteristics from a Case Series. Brain, Behavior, and Immunity. 2020;5:23-29. https://doi.org/10.1016/j.bbi.2020.06.005
Nawabi J, Morotti A, Wildgruber M, Boulouis G, Kraehling H, Schlunk F, Can E, Kniep H, Thomalla G, Psychogios M, Hamm B, Fiehler J, Hanning U, Sporns P. Clinical and Imaging Characteristics in Patients with SARS-CoV-2 Infection and Acute Intracranial Hemorrhage. Journal of Clinical Medicine. 2020;9(8):2543. https://doi.org/10.3390/jcm9082543
Rogg J, Baker A, Tung G. Posterior Reversible Encephalopathy Syndrome (PRES): Another Imaging Manifestation of COVID-19. Interdisciplinary Neurosurgery. 2020;22:100808. https://doi.org/10.1016/j.inat.2020.100808
Franceschi AM, Ahmed O, Giliberto L, Castillo M. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection. American Journal of Neuroradiology. 2020;41(7):1173-1176. https://doi.org/10.3174/ajnr.A6595
Wang H-Y, Li X-L, Yan Z-R, Sun X-P, Han J, Zhang B-W. Potential Neurological Symptoms of COVID-19. Therapeutic Advances in Neurological Disorders. 2020;13:1756286420917830. https://doi.org/10.1177/1756286420917830
Alnefeesi Y, Siegel A, Lui LMW, Teopiz KM, Ho RC, Lee Y, Nasri F, Gill H, Lin K, Cao B, Rosenblat JD, Mcintyre R. Impact of SARS-CoV-2 Infection on Cognitive Functions: A Systematic Review. Frontiers in Psychiatry. 2020;11:1629. https://doi.org/10.13140/RG.2.2.14530.40649
Efe IE, Aydin OU, Alabulut A, Celik O, Aydin K. COVID-19 — Associated Encephalitis Mimicking Glial Tumor. World Neurosurgery. 2020;140:46-49. https://doi.org/10.1016/j.wneu.2020.05.194
Baker HA, Safavynia SA, Evered LA. The ‘third wave’: impending cognitive and functional decline in COVID-19 survivors. British Journal of Anaesthesia. 2021;126(1):44-47. https://doi.org/10.1016/j.bja.2020.09.045
Helms J, Kremer S, Merdji H, Schenck M, Severac F, Clere-Jehl R, Studer A, Radosavljevic M, Kummerlen C, Monnier A, Boulay C, Fafi-Kremer S, Castelain V, Ohana M, Anheim M, Schneider F, Meziani F. Delirium and Encephalopathy in Severe COVID-19: a Cohort Analysis of ICU Patients. Critical Care. 2020;24(1):1-11. https://doi.org/10.1186/s13054-020-03200-1
Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry. 2021;8(5):416-427. https://doi.org/10.1016/S2215-0366(21)00084-5
Vrillon A, Mhanna E, Aveneau C, Lebozec M, Grosset L, Nankam D, Albuquerque F, Feroldi RR, Maakaroun B, Pissareva I, Gherissi DC, Azuar J, François V, Hourrègue C, Dumurgier J, Volpe-Gillot L, Paquet C. COVID-19 in adults with dementia: clinical features and risk factors of mortality — a clinical cohort study on 125 patients. Alzheimer’s Research & Therapy. 2021;13(1):1-8. https://doi.org/10.1186/s13195-021-00820-9
Miners S, Kehoe PJ, Love S. Cognitive impact of COVID-19: looking beyond the short term. Alzheimer’s Research & Therapy. 2020;12(1):1-16. https://doi.org/10.1186/s13195-020-00744-w
Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, Ahluwalia N, Bikdeli B, Dietz D, Der-Nigoghossian C, Liyanage-Don N, Rosner GF, Bernstein EJ, Mohan. Post-acute COVID-19 syndrome. Nature Medicine. 2020;8:1-15. https://doi.org/10.1038/s41591-021-01283-z
Seshadri S, De Erausquin GA, Snyder H, Hosseini AA, Brugha TS, Carrillo M, CNS SARS‐CoV‐2 Consortium. The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning. 2020. Wiley. https://doi.org/10.1002/alz.12255
Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, Ueno M, Sakata H, Kondo K, Myose N, Nakao A, Takeda M, Haro H, Inoue O, Suzuki-Inoue K, Kubokawa K, Ogihara S, Sasaki T, Kinouchi H, Kojin H, Ito M, Onishi H, Shimizu T, Sasaki Y, Enomoto N, Ishihara H, Furuya S, Yamamoto T, Shimada S. A First Case of Meningitis/Encephalitis Associated with SARS-Coronavirus-2. International Journal of Infectious Diseases. 2020;94:55-58. https://doi.org/10.1016/j.ijid.2020.03.062
Khodamoradi Z, Hosseini SA, Saadi MHG, Mehrabi Z, Sasani MR, Yaghoubi S. COVID‐19 Meningitis without Pulmonary Involvement with Positive Cerebrospinal fluid PCR. European Journal of Neurology. 2020;27(12):2668-2669. https://doi.org/10.1111/ene.14536
Tuma RL, Guedes BF, Carra R, Iepsen B, Rodrigues J, Camelo-Filho AE, Kubota G, Ferrari M, Studart-Neto A, Oku MH, Terrim S, Lopes CCB, Neto CEBP, Fiorentino MD, Souza JCC, Baima JPS, Silva T, Perissinotti I, da Graça MMM, Gonçalves M, Fortini I, Smid J, Adoni T, Lucato L, Nitrini R, Gomes H, Castro LH. Clinical, Cerebrospinal Fluid, and Neuroimaging Findings in COVID-19 Encephalopathy: a Case Series. Neurological Sciences. 2020;1-11. https://doi.org/10.1007/s10072-020-04946-w
Montalvan V, Lee J, Bueso T, Toledo JD, Rivas K. Neurological Manifestations of COVID-19 and Other Coronavirus Infections: a Systematic Review. Clinical Neurology and Neurosurgery. 2020;194:105921. https://doi.org/10.1016/j.clineuro.2020.105921
Merello M, Bhatia KP, Obeso JA. SARS-CoV-2 and the Risk of Parkinson’s Disease: Facts and Fantasy. The Lancet Neurology. 2021;20(2):94-95. https://doi.org/10.1016/S1474-4422(20)30442-7
Pilotto A, Masciocchi S, Volonghi I, De Giuli V, Caprioli F, Mariotto S, Ferrari S, Bozzetti S, Imarisio A, Risi B, Premi E, Benussi A, Focà E, Castelli F, Zanusso G, Monaco S, Stefanelli P, Gasparotti R, Zekeridou A, McKeon A, Ashton NJ, Blennov K, Zetterberg H, Padovani A. SARS-CoV-2 Encephalitis is a Cytokine Release Syndrome: Evidences from Cerebrospinal Fluid Analyses. Clinical Infectious Diseases. 2021. https://doi.org/10.1093/cid/ciaa1933
Peng K-P. Association Between COVID-19 and Headache: What Evidence and History Tell Us. SAGE Journals. 2020;40(13):1403-1405. https://doi.org/10.1177/0333102420965969
Bobker SM, Robbins MS. Covid-19 and Headache: A Primer for Trainees. Headache: The Journal of Head and Face Pain. 2020;60(8):1806-1811. https://doi.org/10.1111/head.13884
Amanat M, Rezaei N, Roozbeh M, Shojaei M, Tafakhori A, Zoghi A, Darazam IA, Salehi M, Karimialavijeh E, Lima BS, Garakani A, Vaccaro A, Ramezani M. Neurological Manifestations as the Predictirs of Severity and Mortality in Hospitalized Individuals with COVID-19: A Multicenter Prospective Clinical Study. https://doi.org/10.21203/rs.3.rs-140606/v1
Tolebeyan AS, Zhang N, Cooper V, Kuruvilla DE. Headache in Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Narrative Review. Headache: The Journal of Head and Face Pain. 2020;60(10):2131-2138. https://doi.org/10.1111/head.13980
Weng L-M, Su X, Wang X-Q. Pain Symptoms in Patients with Coronavirus Disease (COVID-19): A Literature Review. Journal of Pain Research. 2021;14:147-159. https://doi.org/10.2147/JPR.S269206
Berger JR. COVID-19 and the Nervous System. Journal of Neurovirology. 2020;26:143-148. https://doi.org/10.1007/s13365-020-00840-5
Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R. Smell and Taste Dysfunction in Patients with COVID-19: a Systematic Review and Meta-analysis. Clinic Proceedings. 2020;95(8);1621-1631. https://doi.org/10.1016/j.mayocp.2020.05.030
Trubiano JA, Vogrin S, Kwong JC, Homes N. Alterations in Smell or Taste — Classic Coronavirus Disease 2019? Clinical Infectious Diseases. 2020;71(16):2307-2309. https://doi.org/10.1093/cid/ciaa655
Lee Y, Min P, Lee S, Kim S-W. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients. Journal of Korean Medical Science. 2020;35(18):e174. https://doi.org/10.3346/jkms.2020.35.e174
Kandemirli SG, Dogan L, Sarikaya ZT, Kara S, Akinci C, Kaya D, Kaya Y, Yildirim D, Tuzuner F, Yildirim MS, Ozluk E, Gucyetmez B, Karaarslan E, Koyluoglu I, Kaya HSD, Mammadov O, Ozdemir IK, Afsar N, Yalcinkaya BC, Rasimoglu S, Guduk DE, Jima AK, Ilksoz A, Ersoz V, Eren MY, Celtik N, Arslan S, Korkmazer B, Dincer SS, Gulek E, Dikmen I, Yazic Mi, Unsa S, Ljama T, Demirel I, Ayyildiz A, Kesimci I, Deveci SB, Tutuncu M, Kizilkilic O, Telci L, Zengin R, Dincer A, Akinci IO, Kocer N. Brain MRI Findings in Patients in the Intensive Care Unit with COVID-19 Infection. Radiology. 2020;297(1):232-235. https://doi.org/10.1148/radiol.2020201697
Emami A, Fadakar N, Akbari A, Lotfi M, Farazdaghi M, Javanmardi F, Rezaei T, Asadi-Pooya AA. Seizure in Patients with COVID-19. Neurological Sciences. 2020;41(11):3057-3061. https://doi.org/10.1007/s10072-020-04731-9
Alshebri MS, Alshouimi RA, Alhumidi NA, Alshaya AI. Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19. SN comprehensive Clinical Medicine. 2020;1-11. https://doi.org/10.1007/s42399-020-00589-2
Nikbakht F, Mohammadkhanizadeh A, Mohammadi E. How Does the COVID-19 Cause Seizure and Epilepsy in Patients? The Potential Mechanisms. Multiple Sclerosis and Related Disorders. 2020;102535. https://doi.org/10.1016/j.msard.2020.102535
Rivera MC, Mastronardi C, Silva-Aldana CT, Arcos-Burgos M, Lidbury BA. Myalgic encephalomyelitis/chronic fatigue syndrome: a comprehensive review. Diagnostics. 2019;9(3):91. https://doi.org/10.3390/diagnostics9030091
Glassford JAG. The neuroinflammatory etiopathology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Frontiers in Physiology. 2017;8:88. https://doi.org/10.3389/fphys.2017.00088
Pietrangelo T, Fulle S, Coscia F, Gigliotti PV, Fanò-Illic G. Old muscle in young body: an aphorism describing the Chronic Fatigue Syndrome. European Journal of translational Myology. 2018;28(3):56-61. https://doi.org/10.4081/ejtm.2018.7688
Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue: Biomedicine, Health & Behavior. 2020;8(2):61-69. https://doi.org/10.1080/21641846.2020.1778227
Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurology. 2011;11(1):1-7. https://doi.org/10.1186/1471-2377-11-37
Lee SH, Shin H-S, Park HY, Kim JL, Lee JJ, Lee H, Won S-D, Han W. Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in middle east respiratory syndrome survivors. Psychiatry Investigation. 2019;16(1):59. https://doi.org/10.30773/pi.2018.10.22.3
Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? Medical Hypotheses. 2021;146:110469. https://doi.org/10.1016/j.mehy.2020.110469
Morris G, Maes M, Berk M, Puri BK. Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop? Metabolic Brain Disease. 2019;34(2):385-415. https://doi.org/10.1007/s11011-019-0388-6
Robinson LJ, Gallagher P, Watson S, Pearce R, Finkelmeyer A, Maclachlan L, Newton JL. Impairments in cognitive performance in chronic fatigue syndrome are common, not related to co-morbid depression but do associate with autonomic dysfunction. PloS One. 2019;14(2):e0210394. https://doi.org/10.1371/journal.pone.0210394
Mueller C, Lin JC, Sheriff S, Maudsley AA, Younger JW. Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy. Brain Imaging and Behavior. 2020;14(2):562-572. https://doi.org/10.1007/s11682-018-0029-4
Rasouli O, Gotaas ME, Stensdotter A-K, Skovlund E, Landrø NL, Dåstøl P, Fors EA. Neuropsychological dysfunction in chronic fatigue syndrome and the relation between objective and subjective findings. Neuropsychology. 2019;33(5):658. https://doi.org/10.1037/neu0000550
Vian J, Pereira C, Chavarria V, Köhler C, Stubbs B, Quevedo J, Kim S-W, Carvalho AF, Berk M, Fernandes BS. The rennin — angiotensin system: a possible new target for depression. BMC Medicine. 2017;15(1):1-13. https://doi.org/10.1186/s12916-017-0916-3
Fazzini E, Fleming J, Fahn S. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson’s disease. Movement disorders: official journal of the Movement Disorder Society. 1992;7(2):153-158. https://doi.org/10.1002/mds.870070210
Camacho-Soto A, Faust I, Racette BA, Clifford DB, Checkoway H, Nielsen SS. Herpesvirus Infections and Risk of Parkinson’s Disease. Neurodegenerative Diseases. 2021;1-7. https://doi.org/10.1159/000512874
Wang H, Liu X, Tan C, Zhou W, Jiang J, Peng W, Zhou X, Mo L, Chen L. Bacterial, Viral, and Fungal Infection‐Related Risk of Parkinson’s Disease: Meta‐analysis of Cohort and Case — control Studies. Brain and Behavior. 2020;10(3):e01549. https://doi.org/10.1002/brb3.1549
Dolatshahi M, Sabahi M, Aarabi MH. Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration. Molecular Neurobiology. 2021;1-16. https://doi.org/10.1007/s12035-020-02236-2
Tejera D, Mercan D, Sanchez‐Caro JM, Hanan M, Greenberg D, Soreq H, Latz E, Golenbock D, Heneka MT. Systemic Inflammation Impairs Microglial Aβ clearance through NLRP 3 Inflammasome. The EMBO Journal. 2019;38(17):e101064. https://doi.org/10.15252/embj.2018101064
Simpson DSA, Oliver PL. ROS generation in microglia: Understanding oxidative stress and inflammation in neurodegenerative disease. Antioxidants. 2020;9(8):743. https://doi.org/10.3390/antiox9080743
Abiodun OA, Ola MS. Role of Brain Renin Angiotensin System in Neurodegeneration: An Update. Saudi Journal of Biological Sciences. 2020;27(3):905-912. https://doi.org/10.1016/j.sjbs.2020.01.026
Ivanova GE, Melnikova EV, Levin OS, et al. Topical issues of rehabilitation of stroke patients against the background of a new coronavirus infection (COVID-19). Resolution of the Council of Experts. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2020;120:8(2):81-87. (In Russ.). https://doi.org/10.17116/jnevro202012008281
Alvarez XA. Cerebrolysin reduces microglial activation in vivo and in vitro: a potential mechanism of neuro-protection. J Neural Transm Suppl. 2000;59:81-292.
Yanlu Z, Chopp M. Iprovement in functional recovery with administration of Cerebrolysin after experimental closed head injury. Neurosurg. 2013;118:67-72. https://doi.org/10.3171/2013.3.JNS122061
Malashenkova IK, Gavrilova SI. Impact of cerebrolysin therapy on neuropsychological state, oxygentransporting function of the blood and systemic inflammation markers in patients with amnestic mild cognitive impairment. Journal of Policlinic Neurology/Rheumatology. 2017;4:34-41.
Hutter-Paier B, Grygar E, Windisch M. Death of cultured telencephalon neurons induced by glutamate is reduced by the peptide derivative Cerebrolysin. New Trends in the Diagnosis and Therapy of NonAlzheimer’s Dementia. 1996;267-273.
Li Z. Sonic Hedgehog Signaling Pathway Mediates Cerebrolysin-Improved Neurological Function After Stroke. Stroke. 2013;44:51-56. https://doi.org/10.1161/STROKEAHA.111.000831
Rockenstein E. Effects of Cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer’s disease. Acta Neuropathol. 2007;113:265-262.
Heiss WD. Cerebrolysin in Patients With Acute Ischemic Stroke in Asia. Results of a Double-Blind, Placebo-Controlled Randomized Trial. Stroke. 2012;43:45-51.
Chang H. Cerebrolysin combined with rehabilitationpromotes motor recovery in patients with severe motor impairment after stroke. BMC Neurology. 2016;34:45-50.
Muresanu DF. Cerebrolysin And Recovery after Stroke (CARS). Stroke. 2016;47:151-159.
Guekht A, et al. Cerebrolysin in vascular dementia: Improvement of clinical outcome in a randomized, double blind, placebo-controlled multicenter trial. Journal of Stroke and Cerebrovascular Diseases. 2011;20:4:310-318.
Chutko LS, Pozhkova AV, Sidorenko VA, et al. Burnout syndrome: quality of life and pharmacotherapy. Psychiatry and Psychopharmacotherapy. 2012;6:67-71. (In Russ.).

Close metadata